Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,961 | 119 | 99.3% |
| Education | $13.89 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $335.38 | 20 | $0 (2024) |
| ABBVIE INC. | $257.29 | 18 | $0 (2024) |
| Amgen Inc. | $205.06 | 12 | $0 (2024) |
| Lilly USA, LLC | $184.00 | 12 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $88.69 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $88.46 | 6 | $0 (2024) |
| Abbott Laboratories | $86.42 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.91 | 5 | $0 (2023) |
| GlaxoSmithKline, LLC. | $67.80 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $65.45 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.14 | 29 | ABBVIE INC. ($100.67) |
| 2023 | $525.35 | 33 | AbbVie Inc. ($139.62) |
| 2022 | $147.63 | 8 | Biohaven Pharmaceutical Holding Company Ltd. ($41.50) |
| 2021 | $15.92 | 1 | Novo Nordisk Inc ($15.92) |
| 2020 | $71.74 | 5 | Lilly USA, LLC ($27.81) |
| 2019 | $205.35 | 13 | Novo Nordisk Inc ($34.23) |
| 2018 | $211.78 | 14 | Amgen Inc. ($41.90) |
| 2017 | $238.36 | 17 | SANOFI-AVENTIS U.S. LLC ($49.55) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VACCINE | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: NEUROLOGY | ||||||
| 06/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Diabetes Care | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Gastroenterology | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.99 | General |
| 04/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes Care | ||||||
| 03/20/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Neuroscience | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 286 | 404 | $64,601 | $14,453 |
| 2022 | 6 | 267 | 402 | $66,107 | $16,381 |
| 2021 | 6 | 318 | 449 | $69,064 | $29,750 |
| 2020 | 7 | 241 | 363 | $49,536 | $19,885 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 164 | $37,324 | $7,135 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 105 | $16,825 | $4,262 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $8,752 | $2,051 | 23.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $1,208 | $637.88 | 52.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 35 | 44 | $220.00 | $215.60 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 16 | $272.00 | $152.32 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 181 | $40,896 | $9,761 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 114 | $18,155 | $4,503 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $5,743 | $1,404 | 24.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 25 | 25 | $800.00 | $435.42 | 54.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 19 | $323.00 | $165.17 | 51.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 32 | 38 | $190.00 | $112.71 | 59.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 126 | 231 | $47,639 | $19,330 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 89 | $13,340 | $5,657 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $6,741 | $3,988 | 59.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 32 | 32 | $1,000 | $569.92 | 57.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 46 | 52 | $260.00 | $156.00 | 60.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 14 | $84.00 | $48.72 | 58.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 85 | 159 | $28,602 | $10,301 | 36.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 102 | $12,576 | $5,048 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $4,781 | $2,796 | 58.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 21 | $2,501 | $1,182 | 47.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 20 | 20 | $597.00 | $346.70 | 58.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 11 | 13 | $364.00 | $143.16 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 19 | 23 | $115.00 | $68.64 | 59.7% |
About Dr. Michael Shaffer, MD
Dr. Michael Shaffer, MD is a Family Medicine healthcare provider based in Marysville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1811154909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Shaffer, MD has received a total of $1,975 in payments from pharmaceutical and medical device companies, with $559.14 received in 2024. These payments were reported across 120 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($1,961).
As a Medicare-enrolled provider, Shaffer has provided services to 1,112 Medicare beneficiaries, totaling 1,618 services with total Medicare billing of $80,470. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Marysville, OH
- Active Since 05/17/2008
- Last Updated 06/26/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1811154909
Products in Payments
- Ozempic (Drug) $126.59
- VRAYLAR (Drug) $106.62
- QULIPTA (Drug) $95.64
- UBRELVY (Drug) $87.94
- MOUNJARO (Drug) $85.75
- Prolia (Biological) $85.71
- NURTEC ODT (Drug) $78.06
- FARXIGA (Drug) $74.59
- Victoza (Drug) $67.99
- FREESTYLE LIBRE 3 (Device) $64.60
- JARDIANCE (Drug) $64.29
- EVENITY (Biological) $61.61
- XIFAXAN (Drug) $58.20
- EMGALITY (Drug) $54.50
- TOUJEO (Drug) $47.21
- Rybelsus (Drug) $43.80
- XARELTO (Drug) $36.03
- Wegovy (Drug) $34.72
- TRELEGY ELLIPTA (Drug) $34.16
- Otezla (Drug) $32.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marysville
Dr. John Colombo, Md, MD
Family Medicine — Payments: $14,480
Dr. Delia Herzog, M.d, M.D
Family Medicine — Payments: $8,380
Dr. Daniel Badenhop, M.d, M.D
Family Medicine — Payments: $8,359
Dr. Jeffrey Moore, M.d, M.D
Family Medicine — Payments: $5,818
Dr. Wendy Summerhill, M.d, M.D
Family Medicine — Payments: $4,265
Igor Nedic, M.d, M.D
Family Medicine — Payments: $2,191